Table 1.
Demographic data and fracture risk factors required by Garvan and POL-RISK calculators and BMD values
| Demographic statistics | Mean (min–max) | Standard deviation (SD) |
| Age | 65.2 (55–87) | 6.9 |
| Weight (kg) | 74 (40–131) | 13.1 |
| Height (cm) | 157.9 (143.5–173.5) | 5.6 |
| BMI (kg/m2) | 29.7 (16.2–47.5) | 5.1 |
| BMI classification | No. of participants | The percentage of study cohort (%) |
| • Underweight | 5 | 1.3 |
| • Normal weight | 65 | 16.7 |
| • Overweight | 150 | 38.6 |
| • Obesity | 169 | 43.4 |
| Glucocorticosteroid use in a dose of at least 5 mg of prednisone (or equivalent) for 6 weeks or longer | 29 | 7.5 |
| Falls during last 12 months | ||
| • No falls | 252 | 64.6 |
| • 1 fall | 65 | 16.7 |
| • 2 falls | 32 | 8.2 |
| • 3 or more falls | 41 | 10.5 |
| Fracture locations (after the age of 40): | No. of fractures | The percentage of overall fractures (%) |
| • Forearm | 49 | 55.7 |
| • Ankle | 31 | 35.2 |
| • Lumbar spine | 4 | 4.55 |
| • Hip | 4 | 4.55 |
| Total fracture count | 88 | |
| DXA results | Mean (min–max) | Standard deviation (SD) |
| BMD (g/cm2) | 0.738 (0.465–1.122) | 0.112 |
| T-score | −0.99 (−3.5–2.5) | 1.05 |
| WHO classification (based on T-score) | No. of participants | The percentage of study cohort (%) |
| • Normal bone density | 171 | 43.8 |
| • Osteopenia | 193 | 49.5 |
| • Osteoporosis | 25 | 6.4 |